The Quality Digest

April 2023 Edition

April 3, 2023

Clinical News

Moderna Monovalent COVID-19 Vaccine to be Discontinued from HHS Distribution Program

The Department of Health and Human Services (HHS) discontinued distribution of Moderna’s monovalent COVID-19 vaccine for adult (ages ≥12 years old) and pediatric (ages 6-11 years old) patients from the current federal distribution program, effective March 13, 2023. Key points and action steps are summarized in this Clinical Advisory.

Read More

Shortage of Common Nebulized Inhalation Solutions Persists

Supply issues of albuterol nebulized solution began in mid-2022, prompting a persistent disruption in its availability and subsequent ongoing shortages of other common nebulized inhalation solutions (e.g. ipratropium-albuterol and levabuterol). PharMerica has issued several communications regarding these drug shortages and will continue to apprise you of the evolving supply issues.

Read More

Short Supply of Transdermal Fentanyl Patches

A short supply of transdermal fentanyl patch products was identified in February 2023. See this Clinical Advisory for action steps pharmacies and facilities may take when facing shortages of this critical medication to support residents requiring pain management.

Read More

Medications with Shortened Expiration Dates

Once certain products are opened and in use, they must be used within a specific timeframe to avoid reduced stability, sterility, and potentially reduced efficacy. This resource, updated in March 2023, contains an abridged list of medications with shortened expiration dates.

Read More

Parkinson’s Webinar: “More Than Motor Symptoms”

Parkinson’s disease is a common condition in long-term care. During Parkinson’s Awareness Month, we are sharing a free program from our pharmaceutical partner Acadia that can help caregivers, family members, and residents understand more about the disease and the impact of psychosis symptoms.

Read More

Article: 7 Steps to Prevent Polypharmacy

Polypharmacy is associated with increased fall risk, cognitive decline, and other adverse effects. Learn how medication optimization can help reduce these risks, keeping residents safe and giving staff more time for direct care and positive interactions.

Read More

Upcoming Events

All webinar times are 1:00pm ET / 12:00pm CT

Tuesday, April 11: MDS 1.18.11 Data Set Changes for Operational, Clinical, Financial, and MDS Managers

Tuesday, April 25: Medication Management in Complex Patients at Home

Tuesday, May 9: The Dos and Don’ts of Antibiotics

Tuesday, May 16: MDS 3.0 Regulatory Update, Survey Activity, and Audit Outcomes — 2023


CMS plans to increase psychotropic drug oversight to include targeted audits. Listen to our latest “Spoonful of Sugar” podcast as hosts TJ Griffin and John O’Connor discuss the importance of implementing a psychotropic stewardship program to prevent headaches, problems, and costs down the line – and get a leg up if CMS decides to mandate such an initiative.

Listen Now

Read the Article